Mounjaro is not indicated for patients with type 1 diabetes or diabetic ketoacidosis
Near the end of treatment planning, patient education matters as much as the prescription itself
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a phase 2 trial
CrossRef Modelos Animais de MASLD/NAFLD: uma reviso narrativa do estado atual e perspectivas futuras Gabriel dos Santos, Fabio de Castro Machado, Ana Beatriz Serrato Carmo, Alvaro Ivanski Sabedotti, Laura Moscardi Millo, Lorenzo Cultz, Mateus Baptista Pizyblski, Leonardo Henrique de Figueiredo Lima, Mrio Cludio Soares Sturzeneker Cuadernos de Educacin y Desarrollo .2025
Supplementary Data 2 (download XLSX DESeq data from RNA analysis
Regular monitoring appointments are crucial